HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Yoshimoto Selected Research

EP 459

1/2002A cysteine protease inhibitor prevents suspension-induced declines in bone weight and strength in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Yoshimoto Research Topics

Disease

8Parkinson Disease (Parkinson's Disease)
04/2008 - 03/2002
6Multiple System Atrophy
04/2004 - 03/2002
4Neoplasms (Cancer)
01/2007 - 02/2002
4Alzheimer Disease (Alzheimer's Disease)
08/2003 - 10/2001
3Synucleinopathies
10/2003 - 07/2002
3Lewy Body Disease (Lewy Body Dementia)
08/2003 - 07/2002
2Carcinogenesis
01/2004 - 02/2002
2Dementia (Dementias)
08/2003 - 03/2002
2Neurodegenerative Diseases (Neurodegenerative Disease)
03/2002 - 02/2002
1Dehydration (Water Stress)
09/2018
1Neurodevelopmental Disorders
09/2008
1Schizophrenia (Dementia Praecox)
09/2008
1Inflammation (Inflammations)
01/2004
1Leukemia
09/2003
1Tauopathies
08/2003
1Pick Disease of the Brain (Pick's Disease)
11/2002
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
06/2002
1Carcinoma (Carcinomatosis)
02/2002
1Neurilemmoma (Schwannoma)
02/2002
1Metabolic Bone Diseases (Osteopenia)
01/2002
1Bone Resorption
01/2002

Drug/Important Bio-Agent (IBA)

14alpha-SynucleinIBA
04/2008 - 10/2001
4AntibodiesIBA
08/2003 - 02/2002
2Anthocyanins (Anthocyanin)IBA
01/2004 - 09/2003
2beta-SynucleinIBA
10/2003 - 11/2002
2Proteins (Proteins, Gene)FDA Link
07/2002 - 03/2002
2Amyloid (Amyloid Fibrils)IBA
06/2002 - 10/2001
1Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2018
1Carbon DioxideIBA
09/2018
1LigandsIBA
09/2008
1Dopamine Agonists (Dopamine Agonist)IBA
02/2008
1caffeic acidIBA
01/2007
1AcidsIBA
01/2007
1caffeoylquinic acidIBA
01/2007
1Dopamine (Intropin)FDA LinkGeneric
08/2006
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2004
1Phosphotransferases (Kinase)IBA
01/2004
1Prothrombin (Factor II)IBA
01/2004
1NF-kappa B (NF-kB)IBA
01/2004
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2004
1CaspasesIBA
01/2004
1Mitogen-Activated Protein KinasesIBA
01/2004
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004
1Amyloid beta-PeptidesIBA
06/2002
1gamma-Synuclein (Persyn)IBA
02/2002
1SynucleinsIBA
02/2002
1SuspensionsIBA
01/2002
1Cysteine Proteinase InhibitorsIBA
01/2002
1CalciumIBA
01/2002
1EP 459IBA
01/2002
1Pharmaceutical PreparationsIBA
01/2002
1Cathepsin KIBA
01/2002
1Initiator Codon (Start Codon)IBA
10/2001
1Protein Isoforms (Isoforms)IBA
10/2001
1Terminator Codon (Termination Codon)IBA
10/2001

Therapy/Procedure

1Chemoprevention
01/2004